Deal will see hVivo manufacture virus for use in human challenge studies
Largest individual investor understood to be an experienced life science investor
Shares in Open Orphan were up almost 5% in late morning trading in London
Company expects revenues from the contract to be recognised across 2022 and 2023
Cathal Friel to continue in executive chairman role under new management structure
Bavarian Nordic vaccine candidate used hVivo challenge trial to gather data
Open Orphan test shows shorter incubation period, effectiveness of lateral flow tests
Contract to study absorption, distribution, metabolism and excretion of drugs in body
Influenza could be a major global issue due to low immunity caused by reduced infection
Study is being carried out under asthma human challenge study model
Healthy volunteers are administered a pathogenic or virulent strain of virus
Seen & heard: global tax rate above 15%; phasing out leasing of social housing; Poolbeg to seek Nasdaq listing
Challenge study is providing valuable insight into biology of the virus, firm says
YOU MAY ALSO LIKE...
Crosswords & puzzles to keep you challenged and entertained
Explore how the historic deal helped bring about peace in Northern Ireland
Start The Search For Your Next Job
Inquests into the nightclub fire that led to the deaths of 48 people
A project examining attitudes about the future of Ireland
Weddings, Births, Deaths and other family notices